当前位置: 首页 > 期刊 > 《健康必读·中旬刊》 > 2011年第11期
编号:12702886
治疗25例伪膜性肠炎(PMC)临床探讨
http://www.100md.com 2011年11月1日 健康必读·中旬刊 2011年第11期
抗生素,免疫抑制剂,腹泻
     [摘 要] 目的:探讨伪膜性肠炎的临床特点,总结其治疗方法。方法:对我院2008年11月—2010年11月收治的25例伪膜性肠炎患者的临床资料进行回顾性分析,包括抗生素使用情况、临床特点以及治疗效果。结果:经确诊的25例膜性肠炎患者,全部停用抗生素,停用或减量免疫抑制剂和糖皮质激素并给予相应治疗24例痊愈,1例死亡。结论:免疫抑制剂抗与抗生素、糖皮质激素联合用药过程中如出现腹泻等症状,应警惕伪膜性肠炎,合理的治疗可提高治愈率。

    [关键词] 伪膜性肠炎;抗生素;免疫抑制剂;腹泻

    [Abstract] Objective Explore the clinical features of pseudomembranous colitis, summarize their treatment. Method Our hospital in November 2008 to 2010 were treated 25cases in November pseudomembranous colitis in patients with clinical data were retrospectively analyzed, including the use of antibiotics, the clinical features and treatment. Result Diagnosed 25cases of membranous colitis patients, all out of antibiotics, disable, or reduction of immunosuppressive agents and corticosteroids and appropriate treatment of 24 cases cured, 1died. Conclusion Immunosuppressant and anti-antibiotics, corticosteroids, such as during combination therapy of diarrhea and other symptoms, should be alert to pseudomembranous colitis, a reasonable treatment can improve the cure rate. . ......

您现在查看是摘要页,全文长 6032 字符